Kintor Pharma Announces Completion of Subject Enrollment in Phase III Clinical Trial of KX-826 for Treatment of Male Androgenetic Alopecia in China

/PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and...

Related Keywords

Peking ,Beijing ,China ,Suzhou ,Jiangsu ,Kintor Pharma ,Zhang Jianzhong ,Yang Qinping ,Prnewswire Kintor Pharmaceutical Limited Pharma ,Kintor Pharmaceutical ,University People Hospital ,Huashan Hospital Affiliated To Fudan University ,Pharmaceutical Limited ,Professor Zhang Jianzhong ,Peking University People ,Professor Yang Qinping ,Huashan Hospital Affiliated ,Fudan University ,Youzhi Tong ,Chief Executive Officer ,